Clinical studies have shown that serum FGF-21 levels positively correlated with obesity and fatty liver [34,35] and that lipid infusion increased FGF-21 levels [36]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.